Back to ENGNW

ACORN CAPITAL ADVISORS, LLC → ENGNW

ACORN CAPITAL ADVISORS, LLC ENGNW Position History

enGene Therapeutics Inc. • Healthcare

Quarters held
2
Latest value
$7.6M
Q3 2026
Peak value
$7.6M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$2.2M
Q3 2026$7.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$7.6M3.81M——
Q2 2026$2.2M1.27M——

Other funds holding ENGNW

Other ACORN CAPITAL ADVISORS, LLC positions

CGON

CG ONCOLOGY INC

$80.4M
CGON

CG ONCOLOGY INC

$80.2M
CGON

CG ONCOLOGY INC

$76.6M
URGN

UROGEN PHARMA LTD

$67M
URGN

UROGEN PHARMA LTD

$61.6M
CGON

CG ONCOLOGY INC

$47M
TRVI

TREVI THERAPEUTICS INC

$40M
CGC

CANDEL THERAPEUTICS INC

$36.5M